Beron Pharma India Private Limited
About Beron Pharma India Private Limited
Data last updated:
Beron Pharma India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the advertising and market research segment of the business services sector. It was incorporated on 30 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2015PTC269715.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dhrubajyoti Kalita and Saurav Doloi.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2019, the company reported a revenue of ₹19.54 Lakh, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹25,246 (net margin 1.3%) and EBITDA of ₹29,180 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 78% over three years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Beron Pharma India Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressLevel Lg 02 & 03 Wing B Art Guild House Phoenix Market City L B S Marg Kurla (W) BKC, Annexe, Mumbai, Maharashtra, India – 400070
- IndustryBusiness Services, Advertising And Market Research
To see the full contact details of Beron Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Beron Pharma India is professional, scientific and technical. In detail, this covers advertising and market research.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M6 | Advertising and market research |
To see the full business activity and turnover split of Beron Pharma India Private Limited, buy the company report.
Financials of Beron Pharma India Private Limited
FY 2019 filings availableBeron Pharma India Private Limited reported revenue of ₹19.54 Lakh (down 21% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 21% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 78%. EBITDA rose 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹29,180 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹25,246 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.5% | |||
| Net Profit Margin | 1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Beron Pharma India Private Limited, buy the company report.
Board of directors of Beron Pharma India Private Limited
Beron Pharma India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhrubajyoti Kalita | Director | 30 Oct 2015 | 10 Years 11 Months | Current |
| Saurav Doloi | Director | 30 Oct 2015 | 10 Years 11 Months | Current |
Peer comparison
Beron Pharma India Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (advertising and market research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Snitch Media Private Limited | ₹19.64 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Big Byte Innovations Private Limited | ₹19.64 Lakh (FY 2025) | 7.0% | Delhi, India | |||
| Anvesak Martech Services Private Limited | ₹19.61 Lakh (FY 2024) | -5.0% | Gurgaon, Haryana, India | |||
| Day Dreamz Services Private Limited | ₹19.6 Lakh (FY 2025) | 167.0% | Ghaziabad, Uttar Pradesh, India | |||
| Cityfeed Private Limited | ₹19.54 Lakh (FY 2024) | 1123.0% | Indore, Madhya Pradesh, India | |||
| Beron Pharma India Private Limitedthis company | ₹19.54 Lakh (FY 2019) | ₹25,246 | 1.3% | -21.0% | Mumbai, Maharashtra, India | |
| Kalshyan Marketing Private Limited | ₹19.5 Lakh (FY 2025) | Shamli, Uttar Pradesh, India | ||||
| Radical Creative Services Private Limited | ₹19.49 Lakh (FY 2024) | -38.0% | Chennai, Tamil Nadu, India | |||
| Rayup India Private Limited | ₹19.48 Lakh (FY 2024) | -55.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Beron Pharma India Private Limited, buy the company report.
Auditor
Beron Pharma India Private Limited is audited by GUPTA ANKIT & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA ANKIT & CO. | FY 2017 | 5199942 |
Shareholding
The shareholding of Beron Pharma India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Beron Pharma India Private Limited, buy the company report.
Legal cases
Beron Pharma India Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kamrup Metro, Assam | Court case (N I Act) | Filed against the company by The HDFC Bank Ltd. | Pending |
To see the full case history of Beron Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Beron Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Beron Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Beron Pharma India Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Nikhilesh Debranungo ceased to be Director on 04 Feb 2017.
Frequently asked questions
Beron Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in advertising and market research, within the business services industry. It was incorporated on 30 October 2015 (11+ years old) and is registered under CIN U74900MH2015PTC269715.
Beron Pharma India has 2 current directors:
- Dhrubajyoti Kalita - Director
- Saurav Doloi - Director
The latest financial statements of Beron Pharma India on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Beron Pharma India is U74900MH2015PTC269715. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Beron Pharma India has 1 court case on record: 1 filed against it. 1 is pending.
Beron Pharma India was incorporated on 30 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Beron Pharma India by revenue are Snitch Media Private Limited, Big Byte Innovations Private Limited, Anvesak Martech Services Private Limited, Day Dreamz Services Private Limited, Cityfeed Private Limited and 3 more, all in the same principal business activity (advertising and market research).
Nikhilesh Debranungo ceased to be Director on 04 Feb 2017. Bapan Deb Nath ceased to be Director on 27 Apr 2016. Dhrubajyoti Kalita was appointed as Director on 30 Oct 2015. Beron Pharma India has 4 board changes on record in total.
The registered office of Beron Pharma India is at Level Lg 02 & 03 Wing B Art Guild House Phoenix Market City L B S Marg Kurla W BKC, Annexe, Mumbai, Maharashtra, India – 400070.
Beron Pharma India operates in the business services industry, in the advertising and market research segment.
The compliance status of Beron Pharma India is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.